PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Mannucci, Edoardo
TI  - No Increased CV Events with DPP-4 Inhibitors
DP  - 2011 Dec 01
TA  - MD Conference Express
PG  - 11--11
VI  - 11
IP  - 11
4099  - http://mdc.sagepub.com/content/11/11/11.1.short
4100  - http://mdc.sagepub.com/content/11/11/11.1.full
AB  - A new meta-analysis suggests that dipeptidyl peptidase-4 (DPP-4) inhibitors are associated with a reduced risk of major cardiovascular events compared with placebo or other treatment, irrespective of trial duration, type of DPP-4 inhibitor, or comparator.